posted on 2000-12-21, 00:00authored byCliff R. Baar, Lee P. Carbray, Michael C. Jennings, Richard J. Puddephatt, Jagadese J. Vittal
Reaction of [PtMe2(μ-SMe2)]2 with cis-1,2-C6H10(NCH-2-C5H4N)2 (1) and cis-1,2-C6H10(NCH-2-C9H6N)2 (2) gives the complexes [PtMe2{cis-1,2-C6H10(NCH-2-C5H4N)2}] (3) and
[PtMe2{cis-1,2-C6H10(NCH-2-C9H6N)2}] (4), respectively (C5H4N = pyridyl; C9H6N =
quinolyl), in which the ligand is bidentate such that each complex is chiral and contains a
free imine substituent. Complexes 3 and 4 react with protic acids, HCl and CF3CO2H, to
form (aminoalkyl)platinum(IV) products that contain a new asymmetric carbon center, often
with very high stereoselectivity. In these products the complex ligand may act as a tridentate
N,N,C donor or, in complexes containing an azaplatinacyclobutane ring, as a tetradentate
N,N,N,C donor. The absolute configurations of five (aminoalkyl)platinum(IV) products were
determined by X-ray crystal structure determinations and gave a benchmark such that the
stereochemistries of other complexes could be assigned by NMR. It is suggested that the
reactions occur by protonation at the free imine nitrogen to give an iminium ion, and the
carbocation then adds to the adjacent platinum(II) center. The initially formed products
may rearrange by mechanisms involving reversible ligand dissociation from platinum(IV)
or deprotonation of the aminoalkyl group.